Results 261 to 270 of about 413,028 (398)

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Herpes simplex virus type-1 infection and spread in a novel porcine corneal explant model is restricted to the epithelium. [PDF]

open access: yesPLoS Pathog
Arshad S   +8 more
europepmc   +1 more source

Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This cohort study of 1793 atopic dermatitis patients (aged ≥ 12) found higher infection rates with Janus kinase inhibitor treatment compared to biologic treatment, particularly for herpes infections, with a history of viral or fungal skin infection as a risk factor associated with infection.
Lian F. van der Gang   +22 more
wiley   +1 more source

Retrograde tracing of breast cancer‐associated sensory neurons

open access: yesJournal of Microscopy, Volume 298, Issue 2, Page 232-244, May 2025.
Abstract Breast cancer is one of the leading causes of mortality among women. The tumour microenvironment, consisting of host cells and extracellular matrix, has been increasingly studied for its interplay with cancer cells, and the resulting effect on tumour progression.
Svetllana Kallogjerovic   +3 more
wiley   +1 more source

Evolution and Diversity in Human Herpes Simplex Virus Genomes

open access: yesJournal of Virology, 2013
Moriah L. Szpara   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy